Brexit Hits Life Science Investment Decisions As UK Risks Exclusion From Key EU Projects
Executive Summary
The chief executives of the APBI and the BIA have told the House of Lords’ Science and Technology Committee that Brexit uncertainty is having an impact on life science investment decisions and that the UK may not be able to benefit from key EU legislative initiatives that it helped to create.